Amalgamated Bank’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,644
| Closed | -$979K | – | 2024 |
|
|
2025
Q4 | $979K | Buy |
9,644
+63
| +0.7% | +$5.06K | 0.01% | 1072 |
|
|
2025
Q3 | $524K | Sell |
9,581
-159
| -2% | -$7.94K | ﹤0.01% | 1293 |
|
|
2025
Q2 | $518K | Sell |
9,740
-913
| -9% | -$46.4K | ﹤0.01% | 1261 |
|
|
2025
Q1 | $461K | Buy |
10,653
+47
| +0.4% | +$2.38K | ﹤0.01% | 1287 |
|
|
2024
Q4 | $596K | Sell |
10,606
-28
| -0.3% | -$1.74K | ﹤0.01% | 1242 |
|
|
2024
Q3 | $724K | Sell |
10,634
-303
| -3% | -$17.1K | 0.01% | 1169 |
|
|
2024
Q2 | $462K | Buy |
10,937
+284
| +3% | +$15.6K | ﹤0.01% | 1326 |
|
|
2024
Q1 | $736K | Sell |
10,653
-18,535
| -64% | -$1.17M | 0.01% | 1166 |
|
|
2023
Q4 | $2.16M | Sell |
29,188
-3,703
| -11% | -$243K | 0.02% | 882 |
|
|
2023
Q3 | $2.24M | Buy |
32,891
+2,011
| +7% | +$171K | 0.02% | 832 |
|
|
2023
Q2 | $2.9M | Buy |
30,880
+1,453
| +5% | +$113K | 0.02% | 719 |
|
|
2023
Q1 | $2M | Sell |
29,427
-4,376
| -13% | -$281K | 0.02% | 865 |
|
|
2022
Q4 | $1.67M | Buy |
33,803
+485
| +1% | +$19.8K | 0.01% | 957 |
|
|
2022
Q3 | $1.08M | Buy |
33,318
+434
| +1% | +$17.9K | 0.01% | 1080 |
|
|
2022
Q2 | $1.29M | Buy |
32,884
+13,774
| +72% | +$737K | 0.01% | 1047 |
|
|
2022
Q1 | $1.34M | Buy |
19,110
+3,722
| +24% | +$272K | 0.01% | 1092 |
|
|
2021
Q4 | $1.2M | Buy |
15,388
+4,871
| +46% | +$430K | 0.01% | 1157 |
|
|
2021
Q3 | $1M | Sell |
10,517
-1,655
| -14% | -$175K | 0.01% | 1239 |
|
|
2021
Q2 | $1.51M | Buy |
12,172
+4,993
| +70% | +$596K | 0.01% | 1086 |
|
|
2021
Q1 | $946K | Sell |
7,179
-418
| -6% | -$57.2K | 0.04% | 608 |
|
|
2020
Q4 | $1.01M | Sell |
7,597
-112
| -1% | -$13.5K | 0.04% | 532 |
|
|
2020
Q3 | $786K | Sell |
7,709
-117
| -1% | -$10.1K | 0.03% | 580 |
|
|
2020
Q2 | $680K | Sell |
7,826
-28,421
| -78% | -$2.27M | 0.03% | 643 |
|
|
2020
Q1 | $2.1M | Sell |
36,247
-794
| -2% | -$64.5K | 0.05% | 336 |
|
|
2019
Q4 | $3.43M | Buy |
37,041
+4,593
| +14% | +$404K | 0.06% | 282 |
|
|
2019
Q3 | $2.93M | Buy |
32,448
+4,187
| +15% | +$477K | 0.06% | 289 |
|
|
2019
Q2 | $3.34M | Buy |
28,261
+974
| +4% | +$98.1K | 0.08% | 236 |
|
|
2019
Q1 | $2.36M | Buy |
27,287
+500
| +2% | +$42.6K | 0.06% | 317 |
|
|
2018
Q4 | $1.69M | Buy |
26,787
+10,399
| +63% | +$714K | 0.05% | 388 |
|
|
2018
Q3 | $1.29M | Sell |
16,388
-11,606
| -41% | -$757K | 0.03% | 548 |
|
|
2018
Q2 | $1.67M | Buy |
27,994
+12,295
| +78% | +$662K | 0.04% | 475 |
|
|
2018
Q1 | $633K | Sell |
15,699
-299
| -2% | -$14.6K | 0.02% | 856 |
|
|
2017
Q4 | $841K | Buy |
15,998
+1,034
| +7% | +$55.2K | 0.02% | 779 |
|
|
2017
Q3 | $705K | Buy |
14,964
+845
| +6% | +$34K | 0.02% | 812 |
|
|
2017
Q2 | $499K | Buy |
14,119
+1,162
| +9% | +$35.9K | 0.02% | 947 |
|
|
2017
Q1 | $306K | Sell |
12,957
-13
| -0.1% | -$258 | 0.02% | 1119 |
|
|
2016
Q4 | $173K | Buy |
12,970
+1,959
| +18% | +$31.6K | 0.01% | 1409 |
|
|
2016
Q3 | $204K | Buy |
11,011
+782
| +8% | +$13.8K | 0.01% | 1259 |
|
|
2016
Q2 | $213K | Buy |
10,229
+148
| +1% | +$1.11K | 0.01% | 1217 |
|
|
2016
Q1 | $68K | Buy |
+10,081
| New | +$64.5K | 0.01% | 1245 |
|
|
2015
Q4 | – | Sell |
-10,052
| Closed | -$181K | – | 1225 |
|
|
2015
Q3 | $181K | Buy |
10,052
+854
| +9% | +$19.6K | 0.02% | 1172 |
|
|
2015
Q2 | $274K | Buy |
+9,198
| New | +$231K | 0.03% | 1033 |
|
|
2015
Q1 | – | Sell |
-8,088
| Closed | -$222K | – | 936 |
|
|
2014
Q4 | $222K | Buy |
+8,088
| New | +$197K | 0.03% | 750 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Amalgamated Bank's EXAS Position: Q1 2026 in Review
Amalgamated Bank sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,644 shares — an estimated $979K sold.
Amalgamated Bank first reported a position in EXAS in Q4 2014 and held it in 43 quarters. The position peaked at $3.43M in Q4 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Amalgamated Bank reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 9,644 Exact Sciences shares in Q1 2026, an estimated $979K.
- Amalgamated Bank first reported a position in Exact Sciences in Q4 2014 and held it in 43 quarters.
- Amalgamated Bank's Exact Sciences position peaked at $3.43M in Q4 2019.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.